- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05573620
ACT and Virtual Reality for Public Speaking Fear
Training University Students Through Acceptance and Virtual Reality for Coping Public Speaking Fear: a Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry.
The clinical trial will include a control group (waiting list).
Patients who meet eligibility requirements will be assigned to a waiting list, in vivo exposure and Virtual Reality.
Psychological intervention consisted in a 5-session individual face-to-face delivered ACT-based treatment.
The participants will be assessed through self-report instruments and observational measurements before and after treatment and at 3 months follow-up.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Madrid
-
Villaviciosa de Odón, Madrid, Spain, 28670
- Universidad Europea de Madrid
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Student at European University of Madrid, Spain
- Significant social anxiety (LSAS Liebowitz Social Anxiety Scale)
- Subjective fear intensity and interference > 5/10
Exclusion Criteria:
- Alcohol or drugs abuse
- Psychotropic drug consume
- Following psychological/psychiatric treatment
- Serious mental disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ACT+In vivo exposure
5 individual weekly sessions which included ACT methods + in vivo exposure
|
Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included 'The dreamed professional exercise' -variation on '"imagine your funeral" exercise'-, Ship's captain metaphor, Imaginal exposure, Physicalizing exercise, and Watching thoughts as graffiti.
The audience was made up of university students.
Every session included a 12 minute oral presentation.
Participants were asked to improvise a talk about a new topic (e.g.
violence against women, education system in Spain…).
Participants had 3 minutes to prepare their speech.
Difficulty increased based on each participant's pre assessment (topics and distractors as ringtones, audience whispering...)
|
|
Experimental: ACT+Virtual reality
5 individual weekly sessions which included ACT methods + virtual reality
|
Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included 'The dreamed professional exercise' -variation on '"imagine your funeral" exercise'-, Ship's captain metaphor, Imaginal exposure, Physicalizing exercise, and Watching thoughts as graffiti.
Virtual reality was delivered through Psious platform distributed in Spain by TEA and through a Virtual Reality equipment that included a Samsung S7 mobile and Samsung Gear VR glasses. Every session included a 12 minute oral presentation. Participants were asked to improvise a talk about a new topic (e.g. violence against women, education system in Spain…). Participants had 3 minutes to prepare their speech. Difficulty increased based on each participant's pre assessment (topics and distractors as ringtones, audience whispering...) |
|
No Intervention: Waiting list
Participants assigned to Waiting List arm waited for 5 weeks before receiving treatment (i.e., after completing the measures they continued in the study and then were randomly assigned to ACT+in vivo exposure or ACT+virtual reality arms).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Public Speaking Self-confidence questionnaire PRCS (Paul, 1966)
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Public Speaking Self-confidence questionnaire' assesses public speaking fear.
It is a 12-item, five-point Likert-type scale.
Scores range between 12 and 60.
Higher the score in the questionnaire, indicate higher levels of public speaking fear and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Acceptance and Action Questionnaire (AAQ-II)
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Acceptance and Action Questionnaire' assesses psychological inflexibility.
It is a 7-item, seven-point Likert-type scale.
Scores range between 7 and 49.
Higher scores indicate higher levels of psychological inflexibility and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
|
Change in Cognitive Fusion Questionnaire (CFQ)
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Cognitive Fusion Questionnaire' assesses cognitive fusion (the tendency to believe the literal content of private events).
It is a 7-item, seven-point Likert-type scale.
Scores range between 7 and 49.
Higher scores in the questionnaire indicate higher levels of cognitive fusion and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
|
Change in Liebowitz Social Anxiety Scale LSAS
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Liebowitz Social Anxiety Scale' assesses social anxiety.
It is a 24-item, four-point Likert-type scale.
Scores range between 0 and 72.
Scores above 51 indicates significant social anxiety (González, Bascaran & Saiz, 2001).
Higher the score in the questionnaire, indicate higher levels of social anxiety and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
|
Change in Self-Statements during Public Speaking SSPS
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Self-Statements during public Speaking questionnaire' assesses positive and negative self-statements.
It is a 10-item, six-point Likert-type scale.
It includes two subscales.
Scores in positive self-statements subscale range between 5 and 30.
Higher the score in this subscale, indicate higher levels of positive self-statements and better outcome.
Scores in negative self-statements subscale range between 5 and 30.
Higher the score in this subscale, indicate higher levels of negative self-statements and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
|
Change in Public Speaking Self-efficacy and Fear Questionnaire CAHP
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Public speaking self-efficacy and fear questionnaire' assesses public speaking self-efficacy and public speaking fear.
It is a 12-item, six-point Likert-type scale.
It includes two subscales (self-efficacy and fear).
Scores in self-efficacy subscale range between 12 and 72.
Higher the score in the sef-efficacy subscale, indicate higher levels of public speaking self-efficacy and better outcome.
Scores in public speaking fear subscale range between 12 and 72.
Higher the score in the fear subscale, indicate higher levels of public speaking fear and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
|
Change in Anxiety intensity subjective scale
Time Frame: Change from Baseline psychological inflexibilty at 4 months
|
'Anxiety intensity subjective scale' asesses global self-assessment of intensity of public speaking anxiety VAS-ratings (range from 0 = very low intensity to 10 = very high intensity).
Higher the score in scale, indicate higher levels of public speaking anxiety intensity and worse outcome.
|
Change from Baseline psychological inflexibilty at 4 months
|
|
Change in Anxiety interference subjective scale
Time Frame: Through study completion, an average of 4 months
|
'Anxiety interference subjective scale' assesses global self-assessment of interference of public speaking anxiety VAS-ratings (range from 0 = very low interference to 10 = very high interference).
Higher the score in scale, indicate higher levels of public speaking anxiety interference and worse outcome.
|
Through study completion, an average of 4 months
|
|
Change in Change in Satisfaction with performance subjective scale
Time Frame: Through study completion, an average of 4 months
|
'Satisfaction with performance subjective scale' assesses global self-assessment of satisfaction with performance VAS-ratings (range from 0 = very low satisfaction to 10 = very high satisfaction).
Higher the score in scale, indicate higher satisfaction and better outcome.
|
Through study completion, an average of 4 months
|
|
Change in Behavioral Checklist for Performance Anxiety (Paul, 1966, adapted by Bados, 1986)
Time Frame: Through study completion, an average of 4 months
|
Behavioral Checklist for Performance Anxiety assesses anxiety performance.
It includes using video recordings, 'CODIMG' behavioral observation and analysis coding software.
It is a 14-items checklist.
Scores range between 0 and 14.
Higher the score in the checklist, indicate higher levels of anxiety performance and worse outcome.
|
Through study completion, an average of 4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Francisco Montesinos, Ph.D., Universidad Europea de Madrid
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CIPI/19/052
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Public Speaking Fear
-
Philipps University MarburgRecruitingPublic Speaking Fear | Public Speaking AnxietyGermany
-
Prof. Dominique de Quervain, MDCompletedFear of Public Speaking (Subclinical)Switzerland
-
Drexel UniversityCompletedPublic Speaking | Social FearUnited States
-
University of Colorado, BoulderRecruitingSocial Anxiety Disorder | Public Speaking Fear | Public Speaking Anxiety | Social FearUnited States
-
Philipps University MarburgCompletedPublic Speaking FearGermany
-
University of California, Los AngelesCompletedAnxiety Disorders | Public Speaking FearUnited States
-
Boston University Charles River CampusCompleted
-
Universitat Jaume IRecruitingPublic Speaking AnxietySpain
-
Vilnius UniversityLinkoeping University; Stockholm University; Thomas More University of Applied...Recruiting
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
Clinical Trials on ACT
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsNetherlands
-
Idorsia Pharmaceuticals Ltd.Completed
-
Azusa Pacific UniversityWithdrawnAnxiety Disorders | Stress Disorders, Traumatic | AnxietyUnited States
-
Idorsia Pharmaceuticals Ltd.Terminated
-
Universidad del Valle, ColombiaCompletedEmotional Distress | Psychological Flexibility | Psychological Well-Being | Experiential Avoidance | Cognitive FusionColombia
-
Idorsia Pharmaceuticals Ltd.CompletedPharmacokinetics | Pharmacodynamics | Tolerability | SafetyNetherlands
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
University of CoimbraFundação para a Ciência e a TecnologiaUnknown
-
University College DublinCompletedInflammatory Bowel DiseaseIreland